Evidence map›Paper›PMID 31213103›Full record

ArticleJournal of the American Heart Association2019

Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation.

Shanshan Li, Jin Cheng, Liufu Cui, M Edip Gurol, Deepak L Bhatt, Gregg C Fonarow, Emelia J Benjamin, Aijun Xing, YunLong Xia, Shouling Wu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Ten-year trajectory of Life's Essential 8 and aortic valve calcification.American journal of preventive cardiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Progress of uric acid in cardiovascular disease.Cardiovascular endocrinology & metabolism · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Shanshan Li1 Boston University School of Medicine Boston MA.
Jin Cheng2 Department of Cardiology Kailuan General Hospital Tangshan People's Republic of China.
Liufu Cui3 Department of Rheumatology and Immunology Kailuan General Hospital Tangshan People's Republic of China.
M Edip Gurol4 Massachusetts General Hospital Harvard Medical School Boston MA.
Deepak L Bhatt5 Brigham and Women's Hospital Harvard Medical School Boston MA.
Gregg C Fonarow6 David Geffen School of Medicine University of California Los Angeles CA.
Emelia J Benjamin1 Boston University School of Medicine Boston MA.
Aijun Xing2 Department of Cardiology Kailuan General Hospital Tangshan People's Republic of China.
YunLong Xia7 Department of Cardiology First Affiliated Hospital of Dalian Medical University Dailian People's Republic of China.
Shouling Wu2 Department of Cardiology Kailuan General Hospital Tangshan People's Republic of China.
Xiang Gao8 Department of Nutritional Sciences Pennsylvania State University State College PA.
Kailuan General Hospital · CNBoston University · USHarvard University · USDalian Medical University · CNPennsylvania State University · USUniversity of California System · US

Funding

IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
AFGen Consortium: Atrial Fibrillation Genomics to Functional AnalysesR01HL128914 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2015 to 2018
$3.1M
NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL128914
6 · The paper itself

Abstract

Background Current evidence on the association between serum urate and risk of atrial fibrillation ( AF ) is limited by cross-sectional designs and 1-time measurement of serum urate. The roles of serum urate, gout-related inflammation, and systemic inflammation in the etiology of AF are currently unknown. This gap is important, given that systemic inflammation is a recognized risk factor for AF . Methods and Results We conducted a prospective cohort study of 123 238 Chinese patients from 2006 to 2014. Serum urate concentrations were measured in 2006, 2008, 2010, and 2012. Incident AF cases were identified via biennial 12-lead ECG assessment. We used a Cox proportional hazards model to examine the sex-specific associations of cumulative average serum urate and changes in serum urate accounting for baseline level with risk of incident AF . We also assessed the joint associations of serum urate and high-sensitivity C-reactive protein levels. Comparing extreme categories, participants with the highest quintile of serum urate had 1.91-fold higher risk of AF (adjusted hazard ratio: 1.91; 95% CI, 1.32-2.76; P=0.001 for trend). Participants with both high serum urate and high-sensitivity C-reactive protein had 2.6-fold elevated risk of incident AF compared with those with normal levels of serum urate and high-sensitivity C-reactive protein (adjusted hazard ratio: 2.63; 95% CI, 1.63-4.23). Conclusions High serum urate levels and increases in serum urate over time were associated with increased risk of incident AF . Patients with high levels of both serum urate and high-sensitivity C-reactive protein had substantially higher risk of AF .

Indexed as

AdultAtrial FibrillationChinaCohort StudiesC-Reactive ProteinElectrocardiographyFemaleHumansHyperuricemiaIncidenceMaleMiddle AgedProportional Hazards ModelsProspective StudiesRisk FactorsUric AcidC-Reactive ProteinUric Acidatrial fibrillationepidemiologyuric acid

Identifiers

PMID31213103
PMCPMC6662349
OpenAlexW2949400734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.